Liquidity & Technical

Liquidity & Technical

Figures converted from INR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

The reported tape volume on this single venue clears only about $0.55M per day, which caps practical 5-day implementation at roughly $11.6M for a 5% portfolio weight — meaning anything above a small India-focused fund is capacity-constrained on this data set. Tape says the post-split correction has been bought back to within 4% of the all-time high on a 14.7x volume thrust, with momentum strongly positive but RSI(14) now stretched at ~77.

Price snapshot

Returns are computed on split-adjusted prices (the company executed a 5-for-1 sub-division on 2025-12-26; the raw price feed shows a one-day –80% gap that is purely mechanical). A peer-broking-basket beta proxy of ~1.1 is used; the post-listing history is too short and split-distorted for a clean regression.

Trend — full-history price vs 50/200-day SMA

Price is above the 200-day moving average by 19.6% ($17.26 vs $14.43). The 50-day ($13.45) is still below the 200-day, leaving the lagging cross signal in death-cross territory from 2026-02-17 — but the spot rally has run well clear of both averages, which is the more decision-relevant fact. Regime read: emerging uptrend after a four-month corrective base, not a sustained downtrend.

Relative strength

Momentum — RSI and MACD

RSI(14) is ~77 — meaningfully overbought and the highest reading since the pre-split rally peak. MACD histogram has flipped from negative to a sharply positive ~$0.23, with the line accelerating above signal. Both indicators read the same way: near-term momentum is unambiguously bullish, but the slope is the kind that typically precedes a 1–3 week consolidation rather than a clean continuation. This is a buy-the-trend, not chase-the-print, configuration.

Volume, volatility, and sponsorship

Twelve-month tape on this venue averaged about 154,000 shares per session split-adjusted, but 50-day average volume has compressed by roughly 90% since the mid-2025 peak — from ~280,000 shares/day post-split-equivalent to ~25,000 today. The latest session printed 372,601 shares (14.7x the 50d average) on a +10.6% close — a single-day institutional thrust that ends the volume drought. Whether that thrust is the start of a re-engagement cycle or a one-off is the question Anchor 8 takes a stance on.

Two of the three top historical volume thrusts came on positive closes, including the most recent print — a constructive distribution-vs-accumulation read.

Realized vol sits at 48.1% annualized — between the calm band (p20 ≈ 32%) and median (p50 ≈ 43%) on the company's own short history but inside what would still be the "normal" regime for a mid-cap Indian wealth-management name. The market is not yet demanding a stress-level risk premium; if vol pushes through ~56% (p80) without a fundamental driver, that becomes a tape warning.

Institutional liquidity

This section is for buy-side capacity, not retail charting. The reported figures below come from a single-venue feed; cross-venue NSE volume on a name like NUVAMA is typically several multiples higher in real life, so treat these numbers as a conservative floor. The liquidity engine flagged the verdict as "unknown" because the source manifest lacked a clean shares-outstanding field — we have backfilled the market-cap-percentage columns using the published $3.14B market cap.

Annual turnover at 21.4% of shares outstanding is reasonable for a 2-year-old listing — total reported tape volume sums to roughly $570M over the trailing twelve months. Trailing-252-day ADV is $2.27M versus the very depressed $0.55M of the latest 20 sessions, underscoring how much the post-split engagement has fallen and why the May 8 thrust is notable.

On the available data, a fund building a 5% portfolio position in five trading days at 20% ADV is capped at roughly $11.6M AUM. At a more conservative 10% ADV participation, the same 5% position is capped at ~$5.8M. Even doubling the venue volume to reflect missing NSE flow only moves these caps to ~$23M and ~$11.6M respectively — still small.

A 0.5% issuer-level stake ($15.7M) takes about 134 trading days to liquidate at 20% ADV, or 268 days at 10% — call it 6–13 months. A 1% stake is a 12-month-plus job. These runways say the same thing as the capacity table: NUVAMA is institutionally tradable for size-aware Indian buyers, not for global funds wanting concentrated stakes.

Median 60-day intraday range is 3.07% — above the 2% elevated-friction threshold. Combined with reported ADV, expect implementation cost of 30–60 bps for blocks above $10M even before market-impact slippage.

Technical scorecard

Net stance score: +3 (range −6 to +6) — constructive setup on the 3-to-6-month horizon. The tape is post-correction, base-built, and pushing the prior peak on volume. Two operative price levels: a daily close above $18.01 would confirm the breakout above the 52-week high and put the split-adjusted $17.56 ATH back in scope — the marker that says the recovery has converted into a fresh leg. A daily close below $14.81, just above the 200-day average and the recent congestion shelf, would invalidate the recovery and reopen the $12.70–$11.65 range that defined the post-split base.

Liquidity is the constraint, not the tape. For Indian funds under ~$26M, this is implementable as a 2–5% position over 1–2 weeks; for global funds wanting size, this is a watchlist name where exposure must be built slowly over multiple weeks at 10% ADV — with the explicit acknowledgement that the available volume feed likely understates true cross-venue NSE turnover, which would relax these caps materially if confirmed by a fuller data pull.